Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia. - Wikidata - wikimedia - TriplyDB

Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia.

Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia.

http://www.wikidata.org/entity/Q40446038

about

Influenza vaccines for preventing acute otitis media in infants and children Vaccines for preventing influenza in healthy children Vaccines for preventing influenza in healthy children Estimating influenza vaccine efficacy from challenge and community-based study data Seasonal influenza vaccine policy, use and effectiveness in the tropics and subtropics - a systematic literature review Wheeze as an adverse event in pediatric vaccine and drug randomized controlled trials: A systematic review Protection of young children from influenza through universal vaccination.Safety and immunogenicity following administration of a live, attenuated monovalent 2009 H1N1 influenza vaccine to children and adults in two randomized controlled trials A review of the evidence to support influenza vaccine introduction in countries and areas of WHO's Western Pacific Region Current status of live attenuated influenza vaccine in the United States for seasonal and pandemic influenza.Evaluation of two live attenuated cold-adapted H5N1 influenza virus vaccines in healthy adults.Respiratory health issues in the Asia-Pacific region: an overview.Influenza vaccination coverage rate in children: reasons for a failure and how to go forward.Efficacy of a Russian-backbone live attenuated influenza vaccine among young children in Bangladesh: a randomised, double-blind, placebo-controlled trial The epidemiological impact of childhood influenza vaccination using live-attenuated influenza vaccine (LAIV) in Germany: predictions of a simulation study Vaccination of children with a live-attenuated, intranasal influenza vaccine - analysis and evaluation through a Health Technology Assessment Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis Longevity of B-cell and T-cell responses after live attenuated influenza vaccination in children.Public health impact and cost-effectiveness of intranasal live attenuated influenza vaccination of children in Germany.Seasonal influenza vaccination for children in Thailand: a cost-effectiveness analysis An integrated, multistudy analysis of the safety of Ann Arbor strain live attenuated influenza vaccine in children aged 2-17 years.Anti-influenza serum and mucosal antibody responses after administration of live attenuated or inactivated influenza vaccines to HIV-infected children.Immunogenicity of a quadrivalent Ann Arbor strain live attenuated influenza vaccine delivered using a blow-fill-seal device in adults: a randomized, active-controlled study*Correlation of cellular immune responses with protection against culture-confirmed influenza virus in young children.Effectiveness of seasonal influenza vaccines in children -- a systematic review and meta-analysis.Shedding of live vaccine virus, comparative safety, and influenza-specific antibody responses after administration of live attenuated and inactivated trivalent influenza vaccines to HIV-infected children Efficacy of live attenuated influenza vaccine in children 6 months to 17 years of age.Efficacy of a Russian-backbone live attenuated influenza vaccine among children in Senegal: a randomised, double-blind, placebo-controlled trial.Protective efficacy of live-attenuated influenza vaccine (multivalent, Ann Arbor strain): a literature review addressing interference.Live attenuated influenza vaccine (FluMist®; Fluenz™): a review of its use in the prevention of seasonal influenza in children and adults.Live attenuated intranasal influenza vaccine.Prevention of acute otitis media using currently available vaccines.Mucosal immunity and nasal influenza vaccination.Quadrivalent Ann Arbor strain live-attenuated influenza vaccine.Live attenuated influenza vaccine tetravalent: a clinical review.Efficacy and effectiveness of live attenuated influenza vaccine in school-age children.A systematic review of the efficacy of live attenuated influenza vaccine upon revaccination of children.Assessment of Public Health and Economic Impact of Intranasal Live-Attenuated Influenza Vaccination of Children in France Using a Dynamic Transmission Model.Estimates of the Public Health Impact of a Pediatric Vaccination Program Using an Intranasal Tetravalent Live-Attenuated Influenza Vaccine in Belgium.Live-Attenuated Influenza Vaccine Effectiveness in Children From 2009 to 2015-2016: A Systematic Review and Meta-Analysis

P2860

Q24187165-4C0B2976-4CFC-45D0-9440-D049E6C82783 Q24201525-EEB63935-0AA6-4E57-814B-9E450767EF06 Q24243174-48952A76-9E93-4E58-BB77-805EBEB047B3 Q24655781-90A95D2B-01BE-4438-A37F-C7D508304C64 Q26769664-2B400B52-0578-44C8-953E-552D38D9225E Q26796334-B5B945A5-5ABF-4B0B-B18F-0519A626271C Q27693242-4F71A1B3-8B8E-4971-8172-5B2464904328 Q28748654-07C32E48-C645-49B2-A1BE-29FC61463268 Q30352256-EC4AF323-F333-439D-90FF-25A2655F89BF Q30377205-E02BD921-82C2-41EC-BCFD-5BD37C393AE0 Q30378263-6E5B90FA-D205-4E80-AFEA-10F5C30550D3 Q30394490-4B993C00-953D-46E0-820A-CB736AF780E3 Q30411868-EB930CAD-136E-49F9-BE2D-90835E94CC77 Q30829284-D00EAE75-3F9A-48F5-A121-669E5DF5D8D3 Q31148484-4B212E0A-390D-40C1-A312-86DF773102A6 Q34446848-23C44B6D-2D64-40AD-929E-861D21EC171E Q34783486-59EFF4FA-BE32-42C8-8745-D8F72A2B88AC Q35531941-3FBA5EF9-9228-4A58-BA44-3E9E7A196756 Q35618994-1707C305-A9D3-4434-81D5-C70B6ABD793D Q35642206-559298E0-32D4-470D-9C7F-1524392F95C1 Q35667079-BD9F59E9-8BDC-48F1-8065-40E04322ADA1 Q35789909-04F9F9CD-BC4F-4F42-BDC4-6D298FA5F6EB Q36251617-2F49E9B4-DC36-4FD7-A617-91495C4E8E42 Q36746934-D51D67A6-6264-49F3-B841-BADED6E89A4C Q36870297-609F69BC-D101-420B-8F59-E40F29EAAAEE Q37040671-8B95F7EB-8287-44B1-A995-BE143AB10D73 Q37087100-687F0FF8-3502-41A6-A6A3-799F6F483DDE Q37427256-CAEB1B5A-F454-4CB3-BD81-68F340703CFA Q37919891-135C29F1-C418-4342-AF25-16CE52989124 Q37921281-741D4BA4-1AFD-4613-9998-310789A5E0C5 Q37976534-5A8D39CE-F68E-4790-9BC7-9D295FD87ED6 Q37996088-B52E9C52-89C3-4289-AE64-CD530A104F5D Q38028996-3BD16F90-95A3-41FB-A0FA-553EB231A41D Q38059737-B88A63A8-C944-4B5A-A64B-D78B3873C761 Q38416489-893867C3-8123-47C8-B607-726220AD25A4 Q38587366-5FA27BF2-82D0-4DA7-83E6-58A2F4B4DA8A Q38692107-F701B35A-1AB8-4A65-9524-B66749503AF0 Q39109055-BB224072-9EA9-46D9-939E-CB771A15C395 Q40641724-26E60420-60B1-4436-AE6E-50EEDDF9F141 Q41510419-62EE185B-3114-4797-AF34-77A9E736CCBC

P2860

Efficacy and safety of a live attenuated, cold-adapted influenza vaccine, trivalent against culture-confirmed influenza in young children in Asia.

http://www.wikidata.org/entity/Q40446038

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年学术文章

@wuu

2007年学术文章

@zh-cn

2007年学术文章

@zh-hans

2007年学术文章

@zh-my

2007年学术文章

@zh-sg

2007年學術文章

@yue

2007年學術文章

@zh

2007年學術文章

@zh-hant

name

Efficacy and safety of a live ...... nza in young children in Asia.

@en

type

label

Efficacy and safety of a live ...... nza in young children in Asia.

@en

prefLabel

Efficacy and safety of a live ...... nza in young children in Asia.

@en

P1433

Q40446038-68F7D575-1970-4A3C-9213-C3B2F7368216

P1476

Q40446038-66576A4C-E15B-43B9-9810-FA9F1A530F8C

P2093

Q40446038-08C1C54C-B3ED-4B02-AB76-B6F56D965203

Q40446038-15F5AC79-E01A-413A-BEA2-362D9FF4C761

Q40446038-1C01CFC7-9230-4A77-8A87-BEE49FE708DE

Q40446038-2AB5FB28-D547-41FA-9D86-F696EB0662B1

Q40446038-4AC7F6EB-DC67-4EC7-B1D8-2D740A56E663

Q40446038-58EE67D9-1AC5-4DFC-AB38-CFADFCBE6DFA

Q40446038-5F6E28BB-B256-4741-A447-7534AF505EDF

Q40446038-680769EE-D8AC-4FF7-B640-0F1D2CA5FABF

Q40446038-6CE6D221-6486-433F-8DE1-2D606871E8AD

Q40446038-76B6FFAF-3E1F-48E7-BD4B-E864FA37B809

P304

Q40446038-2DED522F-2AFB-4724-891F-B51BE757F60A

P31

Q40446038-342DF28E-9307-4DA3-99DA-82F9303B7B4D

P356

Q40446038-C05E9CBE-956D-497D-92C8-8A6982DE5897

P433

Q40446038-3DE858C6-CD49-489F-ABAA-89889010A463

P478

Q40446038-5CC99ED8-60CE-43DF-B85E-C7BD6C7DFD37

P50

Q40446038-55D2343E-1851-4BB5-A3E7-B76F891F44D3

P577

Q40446038-0B96FE73-6170-4805-9850-A62C6F570866

P698

Q40446038-4EFC7712-27A2-4C03-B1B7-47DC7C134949

P921

Q40446038-BE4769E4-0AE1-46F9-8003-5832CC35BC25

P356

INF.0B013E31806166F8

P1433

Pediatric Infectious Disease Journal

P1476

Efficacy and safety of a live ...... nza in young children in Asia.

@en

P2093

Ahmad Razmpour

http://www.w3.org/2001/XMLSchema#string

Bee Wah Lee

http://www.w3.org/2001/XMLSchema#string

Bruce D Forrest

http://www.w3.org/2001/XMLSchema#string

Chellam Kirubakaran

http://www.w3.org/2001/XMLSchema#string

John S Tam

http://www.w3.org/2001/XMLSchema#string

K Pillai Rajamohanan

http://www.w3.org/2001/XMLSchema#string

Lucy Chai See Lum

http://www.w3.org/2001/XMLSchema#string

Maria Rosario Z Capeding

http://www.w3.org/2001/XMLSchema#string

Pan-Asian CAIV-T Pediatric Efficacy Trial Network

http://www.w3.org/2001/XMLSchema#string

Rudiwilai Samakoses

http://www.w3.org/2001/XMLSchema#string

P304

619-628

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/INF.0B013E31806166F8

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

26

http://www.w3.org/2001/XMLSchema#string

P50

P577

2007-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17596805

http://www.w3.org/2001/XMLSchema#string

P921

attenuated vaccine